EUVIMEDEUVIMED entdecken
Open Access

Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma

Kiruthiga K, Subalakshmi Balasubramanian, Sandhya Sundaram

Cureus · 31.05.2026

DOI: 10.7759/cureus.109982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 31.05.2026. Verfasst von Kiruthiga K und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endometrial carcinoma is a common gynaecological malignancy in which tumor progression is influenced not only by neoplastic cells but also by the tumor microenvironment. Tumor-associated macrophages (TAMs) play a key role in modulating tumor behavior and provide prognostic insights depending on their distribution pattern.

Objectives

To evaluate Tumor-associated macrophages (TAMs) using CD68 immunohistochemistry marker and analyze their spatial distribution in endometrial carcinoma, and to correlate the localization of TAM with tumor grade, stage, myometrial invasion, and lymph node metastasis. Materials and methods This retrospective pilot study was conducted in the Department of Pathology at Sri Ramachandra Medical College and Research Institute from January 2024 to December 2024, using seven formalin-fixed paraffin-embedded tissue samples of histopathologically confirmed endometrial carcinoma. Tissue sections were stained with the CD68 antibody, which highlights TAMs. Their distribution was assessed as stromal, intratumorally, and along the invasive margin. Clinicopathological data were retrieved from lab reports, and the findings were analyzed using Statistical Package for Social Sciences (SPSS), version 16 (SPSS Inc., Chicago, IL)

Results

The mean age of study participants was 63.0 ± 7.28 years, with endometrioid carcinoma being the most common subtype, five cases (71.4%). CD68-positive TAMs showed a heterogeneous distribution, located in the stroma in four cases (57.1%), intratumorally in two cases (28.6%), and at the invasive margin in one case (14.3%). There was no statistically significant association observed between TAM localization and tumor grade (p=1.00) or stage (p=1.00).

Conclusion

TAMs in endometrial carcinoma demonstrate spatial heterogeneity with stromal predominance, suggesting a role in tumor microenvironment modulation. However, CD68-based assessment alone showed no significant association with clinicopathological parameters in our study. Hence, further studies with a larger sample size and additional markers are recommended.

Schlagwörter

Stichwörter der Autor:innen

cd68cluster of differentiationendometrial carcinomaimmunohistochemical markertumor-associated macrophages

Autor:innen und Institutionen

  • Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Zitieren

APA

K, K., Balasubramanian, S., & Sundaram, S. (2026). Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma. Cureus. https://doi.org/10.7759/cureus.109982

Vancouver

K K, Balasubramanian S, Sundaram S. Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma. Cureus. 2026. doi:10.7759/cureus.109982

BibTeX
@article{K2026,
  author = {K, Kiruthiga and Balasubramanian, Subalakshmi and Sundaram, Sandhya},
  title = {Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109982}
}
Kostenlos starten →